02616.HK
CStone Pharmaceuticals
HKSE · Healthcare · Biotechnology · CN
HKD 4.94
+4.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 1.74x
- P/E 2028E
- 25.45x
- P/S forward
- 12.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.51x
- Price / sales
- 13.81x
- Price / cash flow
- -21.01x
Enterprise value
- Enterprise value
- HKD 5.4B
- EV / sales
- 10.96x
- EV / EBITDA
- -14.16x
- EV / EBIT
- -11.93x
- Market cap
- HKD 6.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026